Do incentives from Big Pharma influence the way doctors treat cancer patients? A study published earlier this year in JAMA Oncology says YES.
The first study to evaluate reimbursement policies and clinical care in oncology, the review found that oncologists often change their treatment recommendations and prescriptions based on incentives from the pharmaceutical industry.
(Natural News) Johnson & Johnson (J&J), an iconic household name in the United States, is facing a multitude of lawsuits after it was revealed that the company’s talc baby powder products are contaminated with cancer-causing asbestos – a fact that the company has known about since at least the early 1970s, it turns out. Internal…..Read more